13.38
+0.37
+(2.84%)
At close: January 30 at 4:00:02 PM EST
13.11
-0.27
(-2.02%)
Pre-Market: 7:01:41 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-158,000.00
-306,000.00
438,000.00
-256,000.00
111,000.00
Investing Cash Flow
-107,000.00
194,000.00
-413,000.00
-4,000.00
-434,000.00
Financing Cash Flow
282,000.00
33,000.00
33,000.00
237,000.00
439,000.00
End Cash Position
204,000.00
130,000.00
209,000.00
151,000.00
174,000.00
Income Tax Paid Supplemental Data
--
--
3,000.00
--
--
Capital Expenditure
-11,000.00
-24,000.00
-12,000.00
-26,000.00
-3,000.00
Issuance of Capital Stock
228,000.00
25,000.00
--
220,000.00
434,000.00
Repurchase of Capital Stock
--
--
--
-6.00
-54.00
Free Cash Flow
-169,000.00
-330,000.00
426,000.00
-282,000.00
108,000.00
12/31/2020 - 3/15/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMCR Immunocore Holdings plc
32.61
+3.07%
CGEM Cullinan Therapeutics, Inc.
10.98
-2.40%
DAWN Day One Biopharmaceuticals, Inc.
12.86
-1.15%
MRUS Merus N.V.
41.57
-0.19%
ALXO ALX Oncology Holdings Inc.
1.3050
-10.62%
BCYC Bicycle Therapeutics plc
12.77
-1.62%
IMVT Immunovant, Inc.
22.07
+1.28%
ZLAB Zai Lab Limited
27.84
+2.20%
REPL Replimune Group, Inc.
13.62
-3.20%
SNDX Syndax Pharmaceuticals, Inc.
14.21
-0.21%